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Previous studies have suggested an increased chloride membrane permeability in Duchenne muscular dys- 
trophy (DMD) fibroblasts. We report that an increased chloride efflux with respect o controls is present 
not only in fibroblasts from DMD, but also from two other X-linked muscular dystrophies, Becker and 
Emery-Dreifuss, as well as in clones from DMD carrier females. The latter observation suggests that, at 
least in DMD, the increased chloride efflux phenotype might be subject to iyonization. 
Cl- efflux; Fibroblast; X-linked muscular dystrophy; Duchenne muscular dystrophy; Becker muscular dystrophy; 
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1. INTRODUCTION 
Among the X-linked muscular dystrophies, 
DMD is the most serious and frequent, while BMD 
and EDMD are characterized by a milder course 
and survival into adulthood compatible with a nor- 
mal reproductive function. The biochemic~ 
defects of these X-linked dystrophies are as yet 
unknown. Histopathological features typical of 
primitive muscular dystrophies are observed in 
skeletal muscle from these patients, while other ab- 
normalities have been detected in heart [ 11, ner- 
vous system [2], red blood cells [3], lymphocytes 
[4] and skin fibroblasts [5-81 (review [9]). In par- 
ticular cultured skin fibroblasts might represent a 
suitable model in the search for the basic defect(s) 
of X-linked muscular dystrophy, if it can be con- 
vincingly demonstrated that they express it. 
Recently, Davis and co-workers [lo] have 
described several changes involving the 
Cl--dependent lysosomal proteolytic enzyme 
dipeptidyl aminopeptidase I in DMD fibroblasts. 
The most significant changes were pronounced 
decreases in both enzyme activity and latency. 
These obse~ations led to suggest he presence of 
an underlying abnormality in chloride permeability 
or concentration [lo]. A significant increase in 
membrane permeability of DMD fibroblasts to Cl- 
has been subsequently observed by the same group 
Ill]. 
Here, we report that an increased Cl- efflux 
with respect to controls is present not only in 
fibroblasts from DMD, but also from BMD and 
EDMD patients, as well as in clones from DMD 
carrier females. The latter observation suggests 
that, at least in DMD, the increased chloride efflux 
phenotype might be subject to lyonization. 
Correspondence address: M. Rugolo, Istituto Botanico, 
Via Irnerio 42, 40126 Bologna, Italy 2. MATERIALS AND METHODS 
Abbreviations: DMD, Duchenne muscular dystrophy; Skin fibroblasts, derived from biopsies of the 
BMD, Becker muscular dystrophy; EDMD, Emery upper arm, were cultured in Dulbecco’s modified 
Dreifuss muscular dystrophy Eagle’s medium containing L-glutamine, an- 
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tibiotics (100 U/ml penicillin, 100 fig/ml strep- 
tomycin) and 10% fetal calf serum, in a humidified 
atmosphere of 5% CO2 in 95% air at 37’C. 
Fibroblasts from controls, patients and obligate 
carrier females (with at least one brother and one 
son both affected) were developed in our 
laboratory. For the experiment, cells were seeded 
into multiwell tissue culture plates (2 cm2, Nunc) at 
a density of 4 x lo4 cells per well and allowed to 
grow to confluency in 1 ml of growth medium for 
7 days. Cells were matched for passage number 
-I 5. 
Cloned fibroblasts were obtained by seeding ap- 
prox. 1 cell per well in multiwell plates with a 
feeder layer of male fibroblasts previously treated 
with mitomycin C. Clones from controls and 
DMD carriers were cultured in the same ex- 
perimental set and utilized at complete confluency. 
Chloride efflux studies were performed on con- 
fluent cultures in multiwell plates, at 37°C and in 
air without added COZ, exactly as in [12]. Briefly, 
cells were loaded with the medium containing 
36Cl- (7 &i/ml) for 60-90 min, washed with ice- 
cold 0.25 M sucrose/5 mM Hepes (pH 7.4), and 
then incubated with the incubation medium 
without 36Cl-. At defined times, the medium was 
removed and the cells were dissolved in 0.2 M 
NaOH; aliquots were removed for determination 
of radioactivity and protein content. The first- 
order rate constant for 36Cl- efflux from the 
plasma membrane of fibroblasts was determined 
as described [12]. Efflux parameters for each 
fibroblast line were determined from the best fit of 
the experimental points determined by a computer 
program based on standard non-linear least- 
squares minimization procedure [ 131. Statistical 
evaluation was based on Student’s t-test. 
3. RESULTS 
Cl- efflux under steady-state conditions in nor- 
mal fibroblasts has been shown to be biphasic, due 
to the presence of two intracellular compartments, 
both following first-order exponenti~ decay 
[11,12]. According to this model, the sizes of the 
two compartments are very similar, while the rate 
constants of efflux are quite different. In the pre- 
sent experiments, performed in 12 control 
fibroblast lines (no significant difference being 
observed between male and female lines), the 
314 
average values for the sizes of the two compart- 
ments were 109 rt 26 and 128 rt 50 nmob’mg pro- 
tein, respectively. The average values for the rate 
constants of efflux were 0.081 + 0.020 and 1.000 
-+ 0.113 min-‘, respectively. We have previously 
suggested that the efflux characterized by higher 
value of the rate constant is associated with 
transport across the plasma membrane of 
fibroblasts 1121. As a consequence, the fast-rate 
compartment would correspond to the cytoplasm 
of fibroblasts, while the identity of the slow-rate 
compartment remains unknown. 
In fig. 1, the rate constants of Cl- efflux from 
the fast compartment (k) of fibroblast lines derived 
from male individuals normal and affected by X- 
linked muscular dystrophies have been reported. 
In comparison to controls, the value for the rate 
constant was increased on average by 55, 50 and 
66% in DMD, BMD and EDMD fibroblasts, 
respectively. It is noteworthy that in all the ex- 
periments the value of the k from each cell strain 
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Fig. I. Rate constants of 36Cl- efflux from lines of 
fibroblasts derived from male individuals: (0) N, 
normal; (e) DMD; (m) BMD; (A) EDMD. The values 
shown represent the average for each line determined in
at least two experiments. The differences between 
normal and DMD, BMD and EDMD lines were 
statistically significant (P < 0.001; P < 0.01; P < 0.001, 
respectively). The horizontal bars are the means of the 
values. 












Fig.2. Rate constants of 3%X efflux from lines of 
fibroblasts derived from female individuals: (0) N, 
normal; (e) DMD; ( n ) BMD; (A) EDMD. The values 
shown represent he average for each line determined in 
at least two experiments. 
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Fig.3. Rate constants of 36C1- efflux from clones of 
fibroblasts derived from a normal female individual (0) 
and two DMD carrier females (w, l ). If the highest 
value of rate constant observed among normal clones is 
taken as threshold, the clones from the two DMD 
carriers fall into two different groups with significantly 
different rate constant (P < 0.001). 
higher than that of controls. No significant dif- 
ferences were observed on the rate constants from 
the slow compartment or on the amplitudes, in 
nmol/mg protein, of the two compartments. 
Fig.2 shows the rate constant of Cl- efflux from 
female individuals. It can be observed that the 
values of the rate constant for DMD and BMD car- 
riers were very heterogeneous, ranging between 
those of controls and those of affected male in- 
dividuals. The values of the rate constant of efflux 
in EDMD carriers resulted to be identical to those 
obtained in controls. 
Fig.3 shows the values of the rate constant ob- 
tained in different clones derived from a control 
female and from two DMD carriers. A population 
of clones with rate constant values significantly 
higher than those found in clones from the control 
female occurs in both DMD carriers, who also pre- 
sent a second population of clones with rate cons- 
tant values not significantly different from the 
control clones. 
4, DISCUSSION 
Our data demonstrate that in fibroblasts derived 
from patients with X-linked muscular dystrophies 
the kinetics of Cl- efflux is altered, with a signifi- 
cant increase of the rate constant of efflux through 
the plasma membrane. The alteration described in 
this investigation in DMD fibroblasts is in good 
agreement with previous results [ 111. In the latter 
studies, however, the increase in the average value 
for the rate constant of efflux was less pronounced 
(+ 30%). The alteration described here in BMD 
and EDMD fibroblasts, to the best of our 
knowledge, has not been previously reported. The 
increased Cl- efflux observed in BMD is not very 
surprising since the most recent molecular genetic 
evidence [14-161 makes it likely that mutations 
causing DMD or BMD affect the same gene or a 
family of closely related genes. In contrast, the 
altered Cl- efflux observed in EDMD is more dif- 
ficult to explain, because the locus responsible for 
the latter disorder is located in a region of the long 
arm of the X chromosome which is clearly dif- 
ferent from that of the DMD-BMD locus(i) 
[17,18]. The alteration in Cl- efflux shared by the 
three X-linked muscular dystrophies might 
therefore be explained as a secondary phenomenon 
or as a common cellular phenotype due to muta- 
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tions in two different subunits of the same protein. 
In addition, the heterogeneous results obtained in 
uncloned fibroblasts from carrier females might 
reflect the percentage of somatic cells carrying the 
X-linked mutation on the genetically active X 
chromosome, according to Lyon’s theory [19]. If 
the hypothesis of lyonization for this phenotype 
expressed in fibroblasts is correct, one would also 
expect to observe an increased Cl- efflux in one of 
the two clonal populations which should be present 
in somatic cells of carriers. The data reported in 
fig.3 indicate that two types of clones can be 
distinguished in fibroblasts of DMD carriers. It 
should be noted, however, that the values of the 
rate constant observed in control clones, as well as 
in one of the two clonal populations from DMD 
carriers (fig.3), are signi~~antly lower than those 
observed in control fibroblasts (figs 1,2). 
This difference among control cells might be ex- 
plained by aging of cloned fibroblasts. Although 
the passage number for clones from a control 
female and from the two DMD carriers was ap- 
proximately the same, it would still be possible that 
the differences observed between the two clonal 
populations present in DMD carriers reflect some 
sort of heterogeneity in aging rather than a true 
lyonization phenomenon. A similar explanation 
has been recently invoked to justify the apparent 
lyonization of the limited proliferative potential of 
cultured myoblasts from DMD carriers [20]. A 
critical test to discriminate whether the increased 
Cl- efflux is subject to lyonization is represented 
by experiments, now under way, with clones of 
fibroblasts from DMD carriers who are also 
heterozygotes for another X-linked phenot~e, 
like a glucose-4-phosphate dehydrogenase defi- 
ciency variant. 
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